GBA1 Parkinson Disease

Neurology·MeSH: Parkinson Disease

Prevalence

151.4 / 100K

Incidence

17.9 / 100K/yr

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for GBA1 Parkinson Disease?

BioSniper tracks 1 drug in development for GBA1 Parkinson Disease across 1 company.

How many clinical trials target GBA1 Parkinson Disease?

There are 1 clinical trial targeting GBA1 Parkinson Disease tracked by BioSniper.

What is the prevalence of GBA1 Parkinson Disease?

The estimated prevalence of GBA1 Parkinson Disease is approximately 151.4 per 100,000 population.

Deep-dive into GBA1 Parkinson Disease

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    GBA1 Parkinson Disease — Drugs in Development & Clinical Trials | BioSniper